The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Maternal use of selective serotonin re‐uptake inhibitors in early pregnancy and infant congenital malformations
Abstract
BACKGROUND: Maternal use of selective serotonin re‐uptake inhibitors (SSRIs) has recently been associated with an increased risk for certain malformations. METHODS: Using the Swedish Medical Birth Register, we identified women who had reported the use of SSRIs in early pregnancy and studied their infants, born between July 1, 1995 and the end of 2004. Congenital malformations were identified from that register, from the Register of Congenital Malformations, and from the Hospital Discharge Register. The effect of drug exposure was studied after adjustment for a number of identified maternal characteristics that could act as confounders. RESULTS: We identified 6,481 women who reported the use of SSRIs in early pregnancy and their 6,555 infants. There was no general increase in malformation risk. An increased risk for cystic kidneys was seen, but this was based on only nine malformed infants, and the pathology varied between these cases. An in‐depth study of cardiovascular defects identified an association between such defects and notably ventricular and atrial septum defects and maternal use of paroxetine but not other SSRIs. No support for a postulated association between SSRI use and infant craniostenosis or omphalocele was found. CONCLUSIONS: Use of SSRIs in early pregnancy does not seem to be a major risk factor for infant malformations. The association between paroxetine use and infant cardiovascular defects may be a result of multiple testing, but is supported by other studies. Birth Defects Research (Part A) 2007. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oberlander, T. F., Warburton, W., Misri, S., Aghajanian, J., & Hertzman, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.898 · Cited by 551
Delivery outcome after the use of antidepressants in early pregnancy
Ericson, A., Källén, B., & Wiholm, B.-E. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050664 · Cited by 284
Self-citationDo Stressful Life Events Affect Duration of Gestation and Risk of Preterm Delivery?
Hedegaard, M., Henriksen, T. B., Secher, N. J., Hatch, M. C., & Sabroe, S. (1996) · Epidemiology · doi:10.1097/00001648-199607000-00001 · Cited by 282
Maternal drug use in early pregnancy and infant cardiovascular defect
KALLEN, B. (2003) · Reproductive Toxicology · doi:10.1016/s0890-6238(03)00012-1 · Cited by 202
Maternal Obesity and Infant Heart Defects
Cedergren, M. I., & Källén, B. A. J. (2003) · Obesity Research · doi:10.1038/oby.2003.146 · Cited by 184
Self-citationAntidepressant drugs during pregnancy and infant congenital heart defect
Källén, B. A. J., & Olausson, P. O. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2005.11.006 · Cited by 149
Self-citationEffects of First-Trimester Fluoxetine Exposure on the Newborn
GOLDSTEIN, D. J. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)00070-7 · Cited by 138
Delivery outcome after infertility—a registry study
Ghazi, H. A., Spielberger, C., & Källén, B. A. J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54238-1 · Cited by 135
Self-citationHallberg, P., & Sjöblom, V. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000150228.61501.e4 · Cited by 134
Paroxetine (Paxil) and congenital malformations
Williams, M. T., & Wooltorton, E. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.051421 · Cited by 59
Källén, B. A. J., & Olausson, P. O. (2001) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2001-263 · Cited by 52
Self-citationMaternal Drug Use, Fertility Problems, and Infant Craniostenosis
Källén, B. A. J., & Robert‐Gnansia, E. (2005) · The Cleft Palate-Craniofacial Journal · doi:10.1597/04-031.1 · Cited by 46
Self-citationNTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine
Hines, R. N., Adams, J., Louis, G. M. B., Faber, W. D., Holson, J. F., Jacobson, S. W., Keszler, M., McMartin, K. E., Segraves, R. T., Singer, L. T., et al. (2004) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20014 · Cited by 33
Maternal smoking and congenital malformations
Källén, K. (2002) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539502000141 · Cited by 20
Cited by
Grote, N. K., Bridge, J. A., Gavin, A. R., Melville, J. L., Iyengar, S., & Katon, W. J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.111 · Cited by 1,882
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Metadata
- Authors
- Källén, B. A. J., & Otterblad Olausson, P.
- Venue
- Birth Defects Research Part A: Clinical and Molecular Teratology
- Publisher
- Wiley
- Published
- 2007-01-10
- Volume
- 79
- Issue
- 4
- Pages
- 301-308
- ISSN
- 1542-0752 (ISSN-L)
- 1542-0760
- OpenAlex
- W2027369712
- Cited by
- 270
- References
- 14
- FWCI
- 28.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.